DNA & Genetics Pfizer to Acquire Metsera for up to $7.3B, Returning to Obesity Drug RaceBy adminSeptember 23, 20250 Pfizer has agreed to acquire Metsera for up to $7.3 billion, the companies said, in a deal that returns the…
